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Objective: To study the incidence of hypertension (HTN), diabetes mellitus and coronary artery 
disease (CAD) in a cohort of adult subjects.
Methods: A total 2159 participants (mean age: 48.6±11.6 years; 1342 males and 817 females) who 
attended the hospital for a comprehensive health check up were recruited and followed-up as a cohort 
for a mean period of 3.5 years. Their baseline and follow-up evaluation included clinical examination, 
biochemical investigations and cardiac check-up.
Results: At baseline, 64% participants were overweight or obese, 44.3% had HTN (grade I or above), 
16.7% had diabetes mellitus with additional 29.3% having impaired fasting glucose or glucose 
intolerance, and 46.6% had metabolic syndrome. The prevalence of CAD at baseline was 6% in males 
and 3% in females. The incidence (per 1000 person-years of follow-up) of HTN, diabetes mellitus and 
CAD was 72.2, 26.3 and 12.2, respectively. 
Conclusion: The burden of cardiometabolic disorders and their risk factors is high in India. Urgent 
remedial public health preventive measures are required to curtail the emerging epidemic of 
cardiometabolic disorders.
Keywords: Hypertension, diabetes mellitus, coronary artery disease, cardiometabolic syndrome.
ABSTRACT
Introduction
 India has a large burden of cardiovascular 
disease (CVD) due to high prevalence and 
suboptimal management of several risk factors 
including diabetes mellitus (DM), hypertension 
(HTN), obesity and dyslipidemia (1-3).  There 
are few cohort studies reported from India, 
which provide data on incidence of coronary 
artery disease (CAD), HTN and DM in 
susceptible middle aged and elderly subjects. 
 A large number of apparently healthy 
subjects undergo preventive health check-up at 
Sitaram Bhartia Institute of Science and 
Research, New Delhi. Their evaluation includes 
detailed clinical history, physical examination 
and several investigations to assess their 
cardiovascular risk status. Many subjects 
undergo repeat evaluation after a variable period 
of time to assess changes in their status 
fol lowing l ife-style modiﬁcations and 
pharmacotherapy as prescribed at the time of the 
ﬁrst visit. We utilized this opportunity to 
establish a follow-up cohort to determine the 
incidence of CAD, DM and HTN. 
Methods
Study Design
 Retrospective-cum-prospective cohort 
study.
 
Setting and Selection of Participants
 Records of 5611 apparently-healthy adult 
subjects (>20 years) participating in preventive 
health check-up (PHC) at Sitaram Bhartia 
Institute of Science and Research, New Delhi 
from January 2000 to September 2009 were 
recruited as potential participants. Those with 
complete baseline information and fulﬁlling the 
eligible minimum follow-up of 150 days or more 
were invited to participate for follow-up 
(n=2453). Of those successfully contacted, 2098 
(85.6%) consented for second evaluation, 13.7% 
refused and 0.7% were reported to have died 
(cause not known). Seventy one of these 2098 
subjects were excluded from analysis on account 
of non-eligibility: age<20 years, period of 
follow-up<150 days, incomplete information 
and certain outliers.
 Another 132 subjects were enrolled 
prospectively from October 2009 onwards, if the 
follow-up data for a minimum of 150 days was 
available. Thus, 2159 individuals formed the 
cohort and were included for analysis (Fig. 1). 
Clinical details were recorded in a structured 
form by a consultant in medicine. Information 
was recorded about the present symptoms, if 
any, with a detailed system review on direct 
questioning. Tobacco consumption, alcohol 
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Fig. 1: Participant ﬂow chart
132 PHC
 
(Prospec ve)
 
(From October 2009 onwards)
5611 PHC Records (Retrospec ve)
(January 2000-September
 
2009)
 
Contacted
 
for follow-up (n=2453)
 
Traced by courier/telephone
 Lost to follow-up (n=3158)
Not traceable by courier/telephone
Consented 
(n=2098; 85.6% contacted)
 
71 found to be
 
ineligible; 2.9% contacted
 
Age<20 years
 
Period of follow-up<150 days
 
Par cipants included for analysis
(n=2159)
Refused 
(n=338; 13.7% contacted)
 
Died  
(n=17; 0.7% contacted)
 
2027 eligible par cipants (82.6% contacted)
Preven ve Health Check-up (PHC)
(N=5743)
81
intake, anthropometry (height and weight) and 
blood pressure were recorded. Biochemical and 
other clinical investigations included plasma 
glucose (fasting and 2 hours after 75 g glucose), 
lipid proﬁle, resting 12 lead electrocardiogram 
(ECG) and treadmill stress test (TMT)/ 
echocard iography.  Deta i l s  o f  cur ren t 
medications, if any, were recorded. Similar 
observations were recorded on follow-up. 
Ethical clearance was obtained from the local 
Institutional Ethics Committee. A written 
informed consent was obtained from each 
subject for the follow-up evaluation. 
Statistical Methods 
 Statistical analysis was undertaken using 
S TATA ( Ve r  9 . 0 ) .  A p p r o p r i a t e  l o g 
transformations were done for variables having 
skewed distributions (plasma glucose, total 
cholesterol, triglycerides, high density 
lipoprotein cholesterol (HDL-c), low density 
lipoprotein cholesterol (LDL-c). Signiﬁcance of 
differences between mean of continuous 
variables at baseline and during follow-up were 
determined using Student's t-test for paired 
values. Student's t-test was used for assessing 
signiﬁcance of difference in the means of 
continuous variables in different categories of 
subjects. Chi-square test was used to compare 
proportions in two groups. 
Results 
Baseline Characteristics
 Of the 2159 participants, 1342 were males 
(mean age 48.5 ±12.0 years) and 817 females 
(mean age 48.8±11.0 years). Their weight, 
height, body mass index (BMI) and important 
physiological and biochemical characteristics 
are summarized in Table 1. One hundred and 
twenty eight of 817 women (15.6%) and 724 of 
1342 men (54.0%) consumed alcohol (<120 
G/week), the difference being highly signiﬁcant 
(p<0.001). Three hundred and sixteen (14.4%) 
were current smokers while 185 (8.5%) had quit 
smoking. Prevalence of current or past smoking 
was signiﬁcantly higher amongst men.
 The men were taller and heavier as 
compared to women, but the BMI was 
signiﬁcantly higher in women. The subjects 
were considered to be overweight and obese if 
-2
their BMI was ≥25 kgm .  The age speciﬁc 
prevalence of overweight and obese was 
signiﬁcantly higher in females as compared to 
males after the age of 60 years (Fig. 2). Only 
35.8% of the participants were in the normal 
-2
weight range (BMI <25.0 kgm ), whereas 
47.5% were overweight and 16.4% were obese 
-2
(≥ 30 kgm ) (4).  If WHO recommended criteria 
for Asian population (5) were used (BMI  23 
- 2
kgm ) for classiﬁcation of normal and 
overweight, 84.5% were overweight or obese. 
 Subjects were labeled hypertensive if their 
systolic blood pressure was ≥140 mmHg and/or 
the diastolic pressure was ≥90 mmHg, or if they 
were receiving anti-hypertensive medications 
(6). HTN grade I or above (6) was noted in 955 
(44.3%) of the participants (Table 2). The 
prevalence of HTN increased with age and was 
higher in males as compared to females (Fig. 2), 
particularly in the age groups below 50 years.
 Fifty-four percent of the subjects had 
normal fasting and postprandial plasma glucose 
values (<100 and <141 mg/dl, respectively), 
whereas another 29.3% had pre-diabetes 
(impaired fasting glucose: fasting plasma 
glucose between 100 and 125 mg/dl or impaired 
glucose tolerance: postprandial glucose between 
140 and 199 mg/dl). Three hundred and ﬁfty-
eight subjects (16.7%) had DM; the diagnosis 
was made if their fasting or postprandial plasma 
glucose was ≥125 or ≥200 mg/dl, respectively, 
or they were on antidiabetic medications. The 
prevalence of DM increased with age in both 
males and females (Fig. 2). 
 Participants were considered to have 
dyslipidemia if serum triglyceride was               
≥ 150mg/dL and/or if HDL-c was <40 mg/dL in 
males and <50 mg/dL in females. Using this 
criterion, dyslipidemia was present in more than 
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Fig. 2: Age and gender-speciﬁc prevalence of overweight/obesity, metabolic syndrome, 
dyslipidemia, hypertension, diabetes mellitus and coronary artery disease at baseline
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half of the subjects. There was a trend for decline 
in the prevalence of dyslipidemia with 
advancing age in male subjects only (Fig. 2).
 Metabolic syndrome (MS) was diagnosed 
if any three of the following 5 were present 
(modiﬁed from Adult Treatment Panel III (6) 
criteria as waist circumference was not recorded 
-2
in all subjects): (i) BMI ≥25.0 kgm  which was 
used as a surrogate for increased waist 
circumference; (ii) Systolic blood pressure >130 
mmHg or diastolic pressure >85 mmHg;  (iii) 
Serum triglycerides ≥150 mg/dL; (iv) Serum 
HDL-c <40 mg/dL in males or <50 mg/dL in 
females; and (v) Fasting plasma glucose >100 
mg/dL. Using these criteria for clinical 
diagnosis, 46.6% of the subjects had metabolic 
syndrome. There was no gender difference in 
prevalence of MS. The prevalence of MS 
increased with age in male subjects only (Fig. 2).      
  
 CAD was deﬁned to be present if an 
individual gave a history of pre-existent disease 
diagnosed by a cardiologist or had undergone an 
intervention for the same (angioplasty/coronary 
artery bypass grafting). It was also diagnosed if 
on the current evaluation, the echocardiography, 
ECG and/or TMT were compatible with the 
diagnosis in the opinion of a consultant 
cardiologist. The prevalence of CAD increased 
with age. It was signiﬁcantly higher in males 
compared to females above 50 years of age (Fig. 
2).
Changes in Baseline Characteristics on 
Follow-up
 Gender speciﬁc changes in important 
parameters are shown in Table 1.  Notably, there 
was a mild increase in weight, BMI and fasting 
plasma glucose in both males and females on 
follow-up. Height decreased signiﬁcantly in 
females only. Diastolic blood pressure and post-
prandial glucose decreased signiﬁcantly in both 
males and females, whereas LDL-c decreased 
signiﬁcantly in males only.  The number of 
patients taking antihypertensive and anti-
diabetic medication and lipid lowering drugs 
was signiﬁcantly greater on follow-up (results 
not included in the Table).
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Table 2: Gender-speciﬁc baseline prevalence of hypertension, diabetes mellitus, 
pre-diabetes and coronary artery disease 
Disease
Males Females Total
n/N* Incidence (per 1000 
person years) (95% CI)
 
n/N*  Incidence (per 1000 
person years) (95% CI)
 
n/N*  Incidence (per 1000 
person years) (95% CI)
Hypertension 192/692
 
75.4 (70.1-81.8)
 
118/500
 
66.8 (61.7-72.8)
 
310/1192
 
72.2 (68.2-76.2)
Diabetes Mellitus 113/1070
 
29.0 (27.4-30.6)
 
49/659
 
21.5 (20.1-22.9)
 
162/1729
 
26.3 (25.0-27.2)
Pre-Diabetes
#
229/632
 
97.1 (89.9-105.3)
 
103/450
 
64.0 (59.2-69.9)
 
332/1082
 
83.8 (79.2-88.9)
Pre-Diabetes to Diabetes Mellitus
+
86/306 81.4 (73.7-90.9) 40/150 78.5 (67.3-94.2) 126/456 81.0 (74.5-88.7)
Coronary Artery Disease 56/1261 12.2 (11.5-12.7) 34/792 12.4 (11.4-12.8) 90/2053 12.2 (11.6-12.5)
Disease Males Females Total
N % (n)
 
95% CI
 
N
 
% (n)
 
95% CI
 
N
 
% (n) 95% CI
Hypertension 1340 48.1 (645)
 
45.4-50.8
 
815
 
38.0 (310)
 
34.6-41.3
 
2155
 
44.3 (955) 42.2-46.4
Diabetes Mellitus 1330 17.2 (229)
 
15.1-19.2
 
815
 
15.8 (129)
 
13.3-18.3
 
2145
 
16.7 (358) 15.1-18.2
Pre-Diabetes 1330 31.7 (422)
 
29.2-34.2
 
815
 
25.4
 
(207)
 
22.4-28.3
 
2145
 
29.3 (629) 27.3-31.2
Coronary Artery Disease 1342 6.0 (81) 4.7-7.3 817 3.0 (25) 1.8-4.2 2159 4.9 (106) 3.9-5.8
Table 3: Incidence of hypertension, diabetes and CAD during follow-up
*n=number of subjects developing the event at the end of follow-up; N=number of subjects at risk for 
the development of event at baseline;  # Incidence of Pre-diabetes amongst normoglycemic; 
+Incidence of diabetes amongst pre-diabetics
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Table 4: Risk factor for developing incident hypertension, CAD and 
diabetes mellitus (Univariate Analysis)
Parameters
Incident Hypertension Incident CAD Incident Diabetes
No Yes P-value No Yes P-value No Yes P-value
N Mean 
(S.D.)
N Mean 
(S.D.)
 
N Mean 
(S.D.)
 
N Mean 
(S.D.)
 
N Mean 
(S.D.)
N Mean 
(S.D.)
Age (years) 882 44.0 
(10.8)
310
 
48.9 
(10.5)
 
<0.001
 
1963
 
47.9 
(11.4)
 
90
 
53.3             
(10.1)
 
<0.001
 
1567
 
47.0 
(11.5)
162 51.5 
(10.7)
<0.001
BMI                           
(kg/m
2
)
882 25.5 
(3.5)
310
 
26.9  
(4.0)
 
<0.001
 
1963
 
26.2 (3.9)
 
90
 
26.1   
(3.3)
 
0.2708
 
1567
 
26.2 
(3.7)
162 27.7 
(4.2)
<0.001
Diastolic Blood Pressure                          
(mm Hg)
882 75.5 
(6.1)
310
 
77.6     
(6.2) 
<0.001
 
1959
 
81.7 (9.9)
 
90
 
81.8 
(11.8) 
0.9207
 
1564
 
80.9 
(9.9)
162 84.1 
(10.0)
<0.001
Post Prandial Plasma 
Glucose (mg/dL)
859 104.0 
(45.7)
301 117.2 
(56.6)
0.0001 1909 117.4 
(59.1)
89 134.1 
(74.2)
0.0098 1535 96.5 
(27.7)
161 134.1 
(45.2)
<0.001
CAD- Coronary Artery Disease; BMI- Body Mass Index
Incidence of HTN, DM and CAD
 Patients were followed-up for a variable 
period of time with a mean duration of 3.7±2.5 
years for males and 3.5±2.3 years for females. 
The age-speciﬁc incidence of diseases was not 
calculated because of small number of subjects. 
The incidence of HTN, DM and CAD per 1000 
person years follow-up was 72.2, 26.3 and 12.2, 
respectively (Table 3). The incidence of HTN 
and DM was lower in females but difference was 
not statistically signiﬁcant except for incidence 
of pre-diabetes. It is noteworthy that the 
incidence of CAD in men and women was 
similar in this cohort of middle aged and elderly 
subjects, despite higher prevalence of disease 
amongst the males. On univariate analysis, the 
incidence of hypertension, CAD and DM 
increased with age, BMI, diastolic blood 
pressure and post-prandial glucose (Table 4). 
The proportion of subjects taking medications 
for HTN, DM and dyslipidemia increased 
signiﬁcantly on follow-up (data not shown).
Discussion
 The prevalence of overweight and obesity, 
even by the western standards (BMI ≥25 kg m-
2), was high in this sample of subjects drawn 
from a relatively higher socioeconomic status. 
This, however, is comparable to several studies 
from India in urban populations. In conformity 
with earlier reports, we also observed higher 
prevalence of obesity amongst women 
compared to men (7-9). High BMI is associated 
with increased cardiovascular mortality 
globally. It has been reported that this 
association is rather weak in data from India (10, 
11).  This may in part be due to paucity of long 
term cohort studies examining this relationship. 
Pednekar et al (12) reported lowest mortality 
from all causes in Mumbai in the BMI group 25 
to <30 kg m-2; only obese men >60 years of age 
had increased mortality. In our study, BMI was 
not signiﬁcantly associated either with the 
prevalence of CAD at baseline or incident CAD 
during follow-up. Abdominal obesity did not 
emerge as a signiﬁcant predictor of myocardial 
infarction in Interheart Modiﬁable Risk Score 
(13, 14).
 The prevalence of HTN in the present 
study (44.3%) is higher than other reports on 
urban Indian subjects. In a meta-analysis of 25 
studies on urban subjects from different parts of 
India, Anchala et al (15) reported a prevalence of 
33.8% (95% CI 29.7-37.8). This, however, 
included all age groups above 18 years. 
Prevalence of HTN increases signiﬁcantly with 
advancing age as noted by us as well (Fig. 2); this 
explains the higher overall prevalence of HTN in 
the present sample of subjects. The prevalence of 
HTN was signiﬁcantly higher in males. Many 
authors have not reported gender-speciﬁc 
86Burden of Cardiometabolic Disorders
prevalence of HTN as they did not document 
signiﬁcant differences. The incidence of HTN in 
the current cohort was 75.4 per 1000 person 
years for males and 66.8 per 1000 person years 
for females. However, in the community-based 
New Delhi Birth Cohort (NDBC) (16), over an 
average follow-up period of 7 years in a 
relatively younger group of subjects (mean age 
29 years), the incidence of HTN was 42.4 per 
1000 person years for men and 18.0 per 1000 
person years for women. This lower incidence in 
NDBC is related to the age difference. Only 
54.7% of the hypertensive subjects were aware 
of HTN at baseline. This lack of awareness of 
HTN is fairly common all over the world.  Thus, 
overall estimates for the awareness of high blood 
pressure were 25.3% (95% CI 21.4–29.3) for 
rural Indians; and 42.0% (95% CI 35.2– 48.9) for 
urban Indians in a meta-analysis (15).
 The prevalence of DM in 16.7% of the 
subjects with an additional 29.3% having pre-
diabetes is high, but in consonance with 
numerous other reports from India (2). The 
incidence of DM in the present study (26.3 per 
1000 person-years) is comparable to the ﬁnding 
reported by Anjana et al (17) who observed the 
incidence to be 22.2 per 1000 person-years in a 
larger cohort of subjects from rural and urban 
areas of Chennai followed-up for 9.1 years 
(11,629 person-years of follow-up). Again, the 
incidence of DM amongst subjects with pre-
diabetes at baseline in the present study (83.8 per 
1000 person-years) is similar to the ﬁnding 
reported by Anjana et al (17) (78.9 per 1000 
person-years). In the relatively younger NDBC 
the incidence for DM were 10.4 per 1000 person 
years for men and 5.2 per 1000 person years for 
women (16). 
 Several authors have reported the 
prevalence of CAD in India ranging from 3.2-
12.6% over the past two decades. In a 
community-based survey, overall age-adjusted 
prevalence of CAD was reported as 3.5% (4.8% 
in men and 2.6% in women) in a recent report 
from Kerala (18).  Chadha et al in 1990 reported 
the overall prevalence of 3.19% (3.95% in men 
and 2.53% in women) in a random urban sample 
of 13,723 adults in Delhi (19).  The prevalence 
of CAD amongst women has been reported to be 
higher by certain authors (20-22).  However, the 
electrocardiographic criteria for the diagnosis of 
CAD are inaccurate in women (23). The 
prevalence observed in our study (6.0% in men 
and 3.0% in women) is somewhat higher 
compared  to  the  prevalence  noted  in 
community-based surveys (18, 19). There are 
few studies reporting the incidence of CAD in 
Indian subjects. The present study shows that 
with advancing age the incidence of CAD in 
women catches up with the incidence in men. 
This has been emphasized in a recent review on 
the subject (24). The incidence of CVD in a 
cohort of subjects with DM was reported to be 
5.6 per 1000 person-years follow-up (25). This 
compares with the incidence of CAD as 12.2 
subjects per 1000 person years noted in the 
present study after detailed evaluation with 
ECG, TMT and echocardiography for diagnosis 
of CAD.
 The risk factors for the development of 
HTN, DM and CAD noted in the present study 
are  wel l  recognized.  Apar t  f rom age, 
overweight/obesity was the single most 
important factor predicting leading to the HTN 
and DM. Further, increasing age in itself was 
also related to obesity (Fig. 2). Increasing age 
and dysglycemia were noted to be the most 
important factors related to development of 
CAD. These observations emphasize the urgent 
need for  cont ro l l ing  the  epidemic  of 
overweight/obesity in India by instituting life-
style interventions in susceptible populations.
 This study is based on observations in 
subjects attending a tertiary care hospital, and is 
not community-based. Further, the subject 
population is derived from the relatively higher 
socio-economic status and this may not be the 
representative of the community at large. To this 
extent, the ﬁndings of the present study will need 
to be corroborated by larger community-based 
cohort studies representing various socio-
economic strata. We present the ﬁndings of the 
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present study considering that there are few 
cohort studies looking at the incidence of HTN, 
DM, and CAD from India. The baseline 
observations are mostly retrospective and the 
period of follow-up is short and variable. 
Further, the follow-up has been done after usual 
interventions for the risk factors noted at the time 
of the initial evaluation. The ascertainment of 
CAD in this study was not always based on 
angiographic evidence of critical arterial 
narrowing or deﬁnitive procedures such as 
angioplasty or Coronary Artery Bypass Grafting 
(CABPG). Thus, a positive TMT or stress echo 
or stress thallium was considered consistent with 
CAD as opined by a senior cardiologist. 
Considering that these investigative procedures 
have signiﬁcant false positive and false negative 
rates, our estimates of prevalence and incidence 
of CAD could be in some error.
 The high prevalence of MS in the present 
study is similar to other reports. It is reported to 
vary from 8%-43% in men and from 7% to 56% 
in women around the world (26).  Increase in 
prevalence of MS with increasing age has been 
reported by others (27). Gender had no inﬂuence 
on prevalence of MS, similar to the observations 
in the present study. 
 The present study for deﬁnition and 
follow-up of the cohort was not merely an 
observational study. After baseline evaluation, 
all subjects were individually counseled 
regarding diet, exercise, abnormalities detected, 
diagnosis made, pharmacotherapy if required, 
and need for follow-up. The observations made 
at the time of follow-up, therefore, are 
i n ﬂ u e n c e d  b y  c o m p l i a n c e  w i t h 
recommendations made at baseline.  It was 
noted that both systolic and diastolic mean blood 
pressures showed a signiﬁcant decline in both 
men and women on follow-up. The number of 
subjects using anti-hypertensive medications 
also increased signiﬁcantly.  It is well known 
that HTN in early stages results in few symptoms 
and therefore remains undetected. Similarly, 
post-prandial plasma glucose showed a 
signiﬁcant decrease on follow-up, likely because 
of better control of DM by appropriate 
interventions. These ﬁndings suggest that 
routine health check-up in middle aged subjects 
may help in controlling some of the risk factors 
for cardiometabolic disorders. 
Conclusions
 The prevalence of obesity, HTN, DM and 
MS in this hospital-based sample of subjects 
undergoing preventive health check-up was high 
but comparable to other published reports. 
Urgent remedial public health preventive 
measures are required to curtail the emerging 
epidemic of cardiometabolic disorders.               
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